223 related articles for article (PubMed ID: 18252264)
1. HER-2/neu targeting for recurrent vulvar Paget's disease A case report and literature review.
Karam A; Berek JS; Stenson A; Rao J; Dorigo O
Gynecol Oncol; 2008 Dec; 111(3):568-71. PubMed ID: 18252264
[TBL] [Abstract][Full Text] [Related]
2. HER-2/neu expression in Paget disease of the vulva and the female breast.
Brummer O; Stegner HE; Böhmer G; Kühnle H; Petry KU
Gynecol Oncol; 2004 Nov; 95(2):336-40. PubMed ID: 15491754
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod in vulvar Paget's disease: a case report.
Geisler JP; Manahan KJ
J Reprod Med; 2008 Oct; 53(10):811-2. PubMed ID: 19004411
[TBL] [Abstract][Full Text] [Related]
4. Coexisting vulvar Paget's disease and mucinous carcinoma of the breast: a case report and review of the literature.
Aroonroch R; Visetsiri Y; Wongwaisayawan S; Charakorn C; Kanchanapanjapol S; Rochanawutanon M
J Med Assoc Thai; 2012 Jun; 95(6):847-52. PubMed ID: 22774633
[TBL] [Abstract][Full Text] [Related]
5. COX-2 and Her-2/neu are overexpressed in Paget's disease of the vulva and the breast: results of a preliminary study.
Horn LC; Purz S; Krumpe C; Bilek K
Arch Gynecol Obstet; 2008 Feb; 277(2):135-8. PubMed ID: 17701193
[TBL] [Abstract][Full Text] [Related]
6. The expression of HER-2 in extramammary Paget's disease.
Masuguchi S; Jinnin M; Fukushima S; Makino T; Sakai K; Inoue Y; Igata T; Ihn H
Biosci Trends; 2011 Aug; 5(4):151-5. PubMed ID: 21914949
[TBL] [Abstract][Full Text] [Related]
7. Paget's Disease of the Vulva: A Review of 20 Years' Experience.
Parashurama R; Nama V; Hutson R
Int J Gynecol Cancer; 2017 May; 27(4):791-793. PubMed ID: 28441252
[TBL] [Abstract][Full Text] [Related]
8. Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva.
Bartoletti M; Mazzeo R; De Scordilli M; Del Fabro A; Vitale MG; Bortot L; Nicoloso MS; Corsetti S; Bonotto M; Scalone S; Giorda G; Sorio R; Andreetta C; Meacci ML; De Vivo R; Fasola G; Sopracordevole F; Puglisi F
Int J Gynecol Cancer; 2020 Nov; 30(11):1672-1677. PubMed ID: 32998859
[TBL] [Abstract][Full Text] [Related]
9. Limited clinical benefit from trastuzumab in recurrent endometrial cancer: two case reports.
Vandenput I; Vanden Bempt I; Leunen K; Neven P; Berteloot P; Moerman P; Vergote I; Amant F
Gynecol Obstet Invest; 2009; 67(1):46-8. PubMed ID: 18843183
[TBL] [Abstract][Full Text] [Related]
10. Methyl - aminolevulinic acid photodynamic therapy and topical tretinoin in a patient with vulvar extramammary Paget's disease.
Magnano M; Loi C; Bardazzi F; Burtica EC; Patrizi A
Dermatol Ther; 2013; 26(2):170-2. PubMed ID: 23551374
[TBL] [Abstract][Full Text] [Related]
11. HER-2 gene amplification in Paget disease of the nipple and extramammary site: a chromogenic in situ hybridization study.
Bianco MK; Vasef MA
Diagn Mol Pathol; 2006 Sep; 15(3):131-5. PubMed ID: 16932067
[TBL] [Abstract][Full Text] [Related]
12. Extramammary Paget's disease of the vulva recurring in a skin graft.
Geisler JP; Stowell MJ; Melton ME; Maloney CD; Geisler HE
Gynecol Oncol; 1995 Mar; 56(3):446-7. PubMed ID: 7705683
[TBL] [Abstract][Full Text] [Related]
13. Recurrent Paget's disease of the vulva after simple vulvectomy and skin grafting. A case report.
de Jonge ET; Knobel J
S Afr Med J; 1988 Jan; 73(1):46-7. PubMed ID: 2829369
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of recurrent extramammary Paget's disease of the vulva with topical imiquimod 5% cream.
Wang LC; Blanchard A; Judge DE; Lorincz AA; Medenica MM; Busbey S
J Am Acad Dermatol; 2003 Oct; 49(4):769-72. PubMed ID: 14512941
[No Abstract] [Full Text] [Related]
15. Photodynamic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget's disease of the vulva: a pilot study.
Raspagliesi F; Fontanelli R; Rossi G; Ditto A; Solima E; Hanozet F; Kusamura S
Gynecol Oncol; 2006 Nov; 103(2):581-6. PubMed ID: 16793128
[TBL] [Abstract][Full Text] [Related]
16. [Cryosurgery and photodynamic therapy for the treatment of Paget's disease of the vulva: two cases].
Boulard C; Duval Modeste AB; Boullie MC; Marpeau L; Courville P; Joly P
Ann Dermatol Venereol; 2013 Apr; 140(4):282-6. PubMed ID: 23567230
[TBL] [Abstract][Full Text] [Related]
17. Imiquimod therapy for extramammary Paget's disease of the vulva: a viable non-surgical alternative.
Sanderson P; Innamaa A; Palmer J; Tidy J
J Obstet Gynaecol; 2013 Jul; 33(5):479-83. PubMed ID: 23815201
[TBL] [Abstract][Full Text] [Related]
18. [Paget disease of the vulva: resolution after local treatment with imiquimod--report of a case and review of the literature].
Bertozzi S; Londero AP; Fruscalzo A; Marchesoni D; Lellé RJ
Gynakol Geburtshilfliche Rundsch; 2009; 49(4):326-30. PubMed ID: 20530949
[TBL] [Abstract][Full Text] [Related]
19. Primary extramammary invasive Paget's vulvar disease: what is the standard, what are the challenges and what is the future for radiotherapy?
Tolia M; Tsoukalas N; Sofoudis C; Giaginis C; Spyropoulou D; Kardamakis D; Kouloulias V; Kyrgias G
BMC Cancer; 2016 Jul; 16():563. PubMed ID: 27473174
[TBL] [Abstract][Full Text] [Related]
20. Paget Cells in Endometrial and Endocervical Curettings in a Patient With Recurrent Vulvar Paget's Disease.
Clayton EF; Rubin SC; Dumoff KL
Int J Surg Pathol; 2014 Jun; 22(4):374-7. PubMed ID: 23918905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
